Skip to content

Clinical trials

Fallopian Tube Neoplasms trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Country / region: Israel Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20131
20142
20172
20183
20191
20201
20212
20221
20233
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting6
Active, not recruiting4
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
pharmaand GmbH5
AbbVie3
Amgen1
AstraZeneca1
Bristol-Myers Squibb1
Corcept Therapeutics1
Hoffmann-La Roche1
ImmunoGen, Inc.1
Janssen Research & Development, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms24
Ovarian Neoplasms19
Carcinoma, Ovarian Epithelial10
Peritoneal Neoplasms4
Neoplasms3
Recurrence2
Cystadenocarcinoma, Serous1
Endometrial Neoplasms1
Genital Neoplasms, Male1
Pathologic Complete Response1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.